Third-generation antipsychotics in patients with schizophrenia and non-responsivity or intolerance to clozapine regimen: What is the evidence?
O Vasiliu - Frontiers in psychiatry, 2022 - frontiersin.org
Clozapine is considered «the golden standard» for the management of treatment-resistant
schizophrenia, but many patients do not present adequate responsivity even to this …
schizophrenia, but many patients do not present adequate responsivity even to this …
[HTML][HTML] Successful switching from risperidone to cariprazine in a schizophrenic patient with pronounced functional deficit. Case report
JS Schölin, JR Cruz, S Hjorth - Frontiers in Psychiatry, 2023 - ncbi.nlm.nih.gov
A 22-year-old male was admitted to an in-patient psychiatric unit for treatment, after a period
of 2 years of increasing psychotic symptoms corresponding to a very severe case of …
of 2 years of increasing psychotic symptoms corresponding to a very severe case of …
The Polypharmacology of Cariprazine and its Implications to Clinical Indications
This chapter focuses on the third‐generation antipsychotic cariprazine, from its molecular
pharmacology profile to clinical effects. We link the structural features of this bitopic drug with …
pharmacology profile to clinical effects. We link the structural features of this bitopic drug with …
Successful switching from risperidone to cariprazine in a schizophrenic patient with pronounced functional deficit. Case report
J Sahlsten Schölin, J Rodriguez Cruz… - Frontiers in Psychiatry, 2023 - frontiersin.org
A 22-year-old male was admitted to an in-patient psychiatric unit for treatment, after a period
of 2 years of increasing psychotic symptoms corresponding to a very severe case of …
of 2 years of increasing psychotic symptoms corresponding to a very severe case of …
A Versatile Prison Psychiatric Pharmacy Program
NN Patel - Journal of the American Pharmacists Association, 2023 - Elsevier
Background Before the coronavirus disease 2019 (COVID-19) pandemic, 20% of the adult
population in the United States experienced mental illness annually. Since the COVID-19 …
population in the United States experienced mental illness annually. Since the COVID-19 …
[PDF][PDF] UTAH MEDICAID DUR REPORT OCTOBER 2024 ADHERENCE TO LONG-ACTING INJECTABLE OR ORAL ANTIPSYCHOTICS
J Crook, DA MStat - 2024 - medicaid.utah.gov
Schizophrenia is a serious, heterogeneous, chronic psychiatric disorder characterized by
disruptions in perceptual, motor, cognitive, and emotional functioning. 1, 2 Core features …
disruptions in perceptual, motor, cognitive, and emotional functioning. 1, 2 Core features …